The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis

Cancer and Metastasis Reviews

Volumn 25, Issue 4, 2006, Pages 573-587

  Wang, Jianhua ^a   Loberg, Robert ^b   Taichman, Russell S ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chemokines; CXCL12 CXCR4 axis; Tumor cells

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); ALPHA N ACETYLNONA DEXTRO ARGININE AMIDE; ANTINEOPLASTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; CHEMOKINE RECEPTOR CXCR4; LIGAND; POLYPHEMUSIN I; POLYPHEMUSIN II; STROMAL CELL DERIVED FACTOR 1; SYNDECAN 4; TN 14003; TRIBUTYRIN; UNCLASSIFIED DRUG; VORINOSTAT;

ANGIOGENESIS; BONE METASTASIS; BRAIN TUMOR; CANCER CELL; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENESIS; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE COURSE; GENE; HUMAN; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; STEM CELL MOBILIZATION; STIMULATION; STROMA CELL; UNSPECIFIED SIDE EFFECT;

ANIMALS; BONE NEOPLASMS; CHEMOKINES, CXC; HUMANS; LIGANDS; NEOPLASM INVASIVENESS; PROTEIN BINDING; RECEPTORS, CXCR4;

EID: 33846058844     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-006-9019-x     Document Type: Review

References (119)

1. Addison, C. L., Arenberg, D. A., Morris, S. B., Xue, Y. Y., Burdick, M. D., Mulligan, M. S., et al. (2000). The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis. Human Gene Therapy, 11(2), 247-261.
2. Schier, A. F. (2003). Chemokine signaling: Rules of attraction. Current Biology, 13(5), R192-R194.
3. Proudfoot, A. E. (2002). Chemokine receptors: Multifaceted therapeutic targets Nature Reviews Immunology, 2(2), 106-115.
4. Houshmand, P., & Zlotnik, A. (2003). Targeting tumor cells. Current Opinion in Cell Biology, 15(5), 640-644.
5. Burger, J. A., & Kipps, T. J. (2006). CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment. Blood, 107(5), 1761-1767.
6. Aiuti, A., Webb, I. J., Bleul, C., Springer, T., & Gutierrez-Ramos, J. C. (1997). The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. Journal of Experimental Medicine, 185(1), 111-120.
7. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., et al. (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature, 382, 635-638.
8. Yu, L., Cecil, J., Peng, S. B., Schrementi, J., Kovacevic, S., Paul, D., et al. (2006). Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene, 374, 174-179.
9. Gupta, S. K., & Pillarisetti, K. (1999). Cutting edge: CXCR4-Lo: Molecular cloning and functional expression of a novel human CXCR4 splice variant. Journal of Immunology, 163(5), 2368-2372.
10. Ponomaryov, T., Peled, A., Peled, I., Taichman, R. S., Habler, L., Sandbank, J., et al. (2000). Increased production of SDF-1 following treatment with DNA damaging agents: Relevance for human stem cell homing and repopulation of NOD/SCID Mice. Journal of Clinical Investigation, 106(11), 1331-1339.
11. Sun, Y. X., Schneider, A., Jung, Y., Wang, J., Dai, J., Wang, J., et al. (2005). Skeletal localization and neutralization of the SDF-1 (CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. Journal of Bone and Mineral Research, 2, 318-329.
12. Taichman, R. S, Cooper, C., Keller, E. T., Pienta, K. J., Taichman, N. S., & McCauley, L. K. (2002). Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Research, 62(6), 1832-1837.
13. Jung, Y., Wang, J., Schneider, A., Sun, Y-X, Koh-Paige, A., Osman, N., et al. (2006) Regulation of SDF-1 (CXCL12) production by osteoblasts in the hematopoietic microenvironment and a possible mechanisms for stem cell homing. Bone, 38(4), 497-508.
14. Askari, A. T., Goldman, C. K., Forudi, F., Kiedrowski, M. J., & Ellis, S. G., DiCorleto, P. E., et al. (2002). Stromal cell-derived factor-1 mediates stem cell homing in ischemic cardiomyopathy. Circulation, 106(19), II-178.
15. Ratajczak, M. Z., Majka, M., Kucia, M., Drukala, J., Pietrzkowski, Z., Peiper, S., et al. (2003). Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells, 21(3), 363-371.
16. Kollet, O., Shivtiel, S., Chen, Y. Q., Suriawinata, J., Thung, S. N., Dabeva, M. D., et al. (2003). HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34(+) stem cell recruitment to the liver. Journal of Clinical Investigation, 112(2), 160-169.
17. Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., et al. (1998). The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature, 393, 591-594.
18. Schrader, A. J., Lechner, O., Templin, M., Dittmar, K. E., Machtens, S., Mengel, M., et al. (2002). CXCR4/CXCL12 expression and signalling in kidney cancer. British Journal of Cancer, 86(8), 1250-1256.
19. Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., et al. (1999). Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science, 283(5403), 845-848.
20. Ratajczak, M. Z., Kucia, M., Reca, R., Majka, M., Janowska-Wieczorek, A., & Ratajczak, J. (2004). Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Leukemia, 18(1), 29-40.
21. Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska-Wieczorek, A., et al. (2005). Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells, 23(7), 879-894.
22. Kucia, M., Ratajczak, J., Reca, R., Janowska-Wieczorek, A., & Ratajczak, M. Z. (2004). Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells, Molecules & Diseases, 32(1), 52-57.
23. Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., et al. (2002). G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nature Immunology, 3(7), 687-694.
24. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., et al. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Medicine, 10(8), 858-864.
25. Caruz, A., Samsom, M., Alonso, J. M., Alcami, J., Baleux, F., Virelizier, J. L., et al. (1998). Genomic organization and promoter characterization of human CXCR4 gene. FEBS Letters, 426(2), 271-278.
26. Wegner, S. A., Ehrenberg, P. K., Chang, G., Dayhoff, D. E., Sleeker, A. L., & Michael, N. L. (1998). Genomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1. Journal of Biological Chemistry, 273(8), 4754-4760.
27. Feil, C., & Augustin, H. G. (1998). Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochemical and Biophysical Research Communications, 247(1), 38-45.
28. Lazarini, F., Casanova, P., Tham, T. N., De Clercq, E., Arenzana-Seisdedos, F., Baleux, F., et al. (2000). Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes. European Journal of Neuroscience, 12(1), 117-125.
29. Aiuti, A., Tavian, M., Cipponi, A., Ficara, F., Zappone, E., Hoxie, J., et al. (1999). Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors. European Journal of Immunology, 29(6), 1823-1831.
30. Doitsidou, M., Reichman-Fried, M., Stebler, J., Koprunner, M., Dorries, J., Meyer, D., et al. (2002). Guidance of primordial germ cell migration by the chemokine SDF-1. Cell, 111(5), 647-659.
31. Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998). Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature, 393, 595-599.
32. Libert, F., Parmentier, M., Lefort, A., Dumont, J. E., & Vassart, G. (1990). Complete nucleotide-sequence of a putative-g protein coupled receptor - Rdc1. Nucleic Acids Research, 18(7), 1917.
33. Sreedharan, S. P., Robichon, A., Peterson, K. E., & Goetzl, E. J. (1991). Cloning and expression of the human vasoactive intestinal peptide receptor. Proceedings of the National Academy of Sciences of the United States of America, 88(11), 4986-4990.
34. Fredriksson, R., Lagerstrom, M. C., Lundin, L. G., & Schioth, H. B. (2003). The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Molecular Pharmacology, 63(6), 1256-1272.
35. Shimizu, N., Soda, Y., Kanbe, K., Liu, H. Y., Mukai, R., Kitamura, T., et al. (2000). A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses. Journal of Virology, 74(2), 619-626.
36. Balabanian, K., Lagane, B., Infantino, S., Chow, K. Y., Harriague, J., Moepps, B., et al. (2005). The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T Lymphocytes. Journal of Biological Chemistry, 280(42), 35760-35766.
37. Martinez, A., Kapas, S., Miller, M. J., Ward, Y., & Cuttitta, F. (2000). Coexpression of receptors for adrenomedullin, calcitonin gene-related peptide, and amylin in pancreatic beta-cells. Endocrinol, 141(1), 406-411.
38. Jones, S. W., Brockbank, S. M. V., Mobbs, M. L., Le Good, N. J., Soma-Haddrick, S., Heuze, A. J., et al. (2006). The orphan G-protein coupled receptor RDC1: Evidence for a role in chondrocyte hypertrophy and articular cartilage matrix turnover. Osteoarthritis and Cartilage, 14(6), 597-608.
39. Raggo, C., Ruhl, R., McAllister, S., Koon, H., Dezube, B. J., Fruh, K., et al. (2005). Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Research, 65(12), 5084-5095.
40. Bernfield, M., Gotte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., et al. (1999). Functions of cell surface heparan sulfate proteoglycans. Annual Review of Biochemistry, 68, 729-777.
41. Hamon, M., Mbemba, E., Charnaux, N., Slimani, H., Brule, S., Saffar, L., et al. (2004). A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1). Glycobiology, 14(4), 311-323.
42. Charnaux, N., Brule, S., Hamon, M., Chaigneau, T., Saffar, L., Prost, C., et al. (2005). Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/CXCL12. FASEB Journal, 272(8), 1937-1951.
43. Balkwill, F. (2004). Cancer and the chemokine network. Nature Reviews. Cancer, 4(7), 540-550.
44. Muller, C. A., Homey, B., Sato, H., Ge, N., Catron, D., Buchanan, M., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50-56.
45. Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., & Balkwill, F. R. (2001). Epithelial cancer cell migration: A role for chemokine receptors?. Cancer Research, 61(13), 4961-4965.
46. American Cancer Society (2003). American Cancer Society, Cancer Facts & Figures 2003. 1-52.
47. Sun, Y-X, Wang, J., Shelburne, C. E., Lopatin, D. E., Chinnaiyan, A. M., Pienta, K. J., et al. (2003). The expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. Journal of Cellular Biochemistry, 89, 462-473.
48. Krempien, B. (1995). Pathogenesis of bone metastasis and tumor osteopathies. Radiologe, 35(1), 1-7.
49. Weiss, L., Orr, F. W., & Honn, K. V. (1988). Interactions of cancer cells with the microvasculature during metastasis. FASEB Journal, 2(1), 12-21.
50. Liu, A. Y., Roudier, M. P., & True, L. D. (2004). Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile. American Journal of Pathology, 165(5), 1543-1556.
51. Keller, E. T., Zhang, J., Cooper, C. R., Smith, P. C., McCauley, L. K., & Pienta, K. J. (2001). Prostate carcinoma skeletal metastases: Cross-talk between tumor and bone. Cancer Metastasis Reviews, 20(3-4), 333-349.
52. Glinsky, V. V., Glinsky, G. V., Rittenhouse-Olson, K., Huflejt, M. E., Glinskii, O. V., Deutscher, S. L., et al. (2001). The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Research, 61(12), 4851-4857.
53. Cooper, C. R., Bhatia, J. K., Muenchen, H. J., McLean, L., Hayasaka, S., Taylor, J., et al. (2002). The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines. Clinical & Experimental Metastasis, 19(1), 25-33.
54. Engl, T., Relja, B., Marian, D., Blumenberg, C., Muller, I., Beecken, W. D., et al. (2006). CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha(5) and beta (3) integrins. Neoplasia, 8(4), 290-301.
55. 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells. Prostate, 67(1), 61-73.
56. Thalmann, G. N., Anezinis, P. E., Chang, S. M., Zhau, H. E., Kim, E. E., Hopwood, V. L., et al. (1994). Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Research, 54(10), 2577-2581.
57. Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., et al. (2001). Delineation of prognostic biomarkers in prostate cancer. Nature, 412, 822-826.
58. Havens, A. M., Jung, Y., Sun, Y. X., & Taichman, R. S. (2006). The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer, 6(1), 195.
59. Chan, J. Y-H., Lee-Prudhoe, J. E., Jorgensen, B., Ihrke, G., Doyonnas, R., Zannettino, A. C. W., et al. (2001). Relationship between novel isoforms, functionally important domains, and subcellular distribution of CD164/Endolyn. Journal of Biological Chemistry, 276(3), 2139-2152.
60. Fernandis, A. Z., Cherla, R. P., & Ganju, R. K. (2003). Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45. Journal of Biological Chemistry, 278(11), 9536-9543.
61. Chinni, S. R., Sivalogan, S., Dong, Z., Filho, J. C., Deng, X., Bonfil, R. D., et al. (2006). CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microenvironment- associated CXCL12. Prostate, 66(1), 32-48.
62. Wang, J. H., Wang, J., Sun, Y-X, Song, W., Nor, J., Wang, C. Y., et al. (2005). Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cellular Signalling, 17(12), 1578-1592.
63. Kukreja, P., Abdel-Mageed, A. B., Mondal, D., & Agrawal, K. C. (2004). SDF-1 alpha induced NF-kappa B activation promotes adhesion and trans-endothelial migration of prostate cancer cells by enhancing the expression of the chemokine receptor CXCR4. Blood, 104(11), 367A.
64. Fernandis, A. Z., Cherla, R. P., Chernock, R. D., & Ganju, R. K. (2002). CXCR4/CCR5 down-modulation and chemotaxis are regulated by the proteasome pathway. Journal of Biological Chemistry, 277(20), 18111-18117.
65. Zhou, Y., Larsen, P. H., Hao, C., & Yong, V. W. (2002). CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. Journal of Biological Chemistry, 277(51), 49481-49487.
66. Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A., Sun, Y., Schmidt, K., et al. (2003). A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13513-13518.
67. Sehgal, A., Keener, C., Boynton, A. L., Warrick, J., & Murphy, G. P. (1998). CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. Journal of Surgical Oncology, 69(2), 99-104.
68. Zeelenberg, I. S., Ruuls-Van Stalle, L., & Roos, E. (2003). The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Research, 63(13), 3833-3839.
69. Libura, J. D. (2002). CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood, 100(7), 2597-2606.
70. Rossi, D., & Zlotnik, A. (2000). The biology of chemokines and their receptors. Annual Review of Immunology, 18, 217-242.
71. Strieter, R. M., Polverini, P. J., Arenberg, D. A., Walz, A., Opdenakker, G., Van, D., et al. (1995). Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. Journal of Leukocyte Biology, 57(5), 752-762.
72. Salvucci, O., Yao, L., Villalba, S., Sajewicz, A., Pittaluga, S., & Tosato, G. (2002). Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood, 99(8), 2703-2711.
73. Mirshahi, F., Pourtau, J., Li, H., Muraine, M., Trochon, V., Legrand, E., et al. (2000). SDF-1 activity on microvascular endothelial cells: Consequences on angiogenesis in in vitro and in vivo models. Thrombosis Research, 99(6), 587-594.
74. Bautz, F., Rafii, S., Kanz, L., & Mohle, R. (2000). Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment. Experimental Hematology, 28(6), 700-706.
75. Darash-Yahana, M., Pikarsky, E., Abramovitch, R., Zeira, E., Pal, B., Karplus, R., et al. (2004). Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB Journal, 18(11), 1240-1242.
76. Seo, D. W., Li, H., Guedez, L., Wingfield, P. T., Diaz, T., Salloum, R., et al. (2003). TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell, 114(2), 171-180.
77. Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., et al. (2004). Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell, 6(1), 17-32.
78. Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., et al. (2004). Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell, 6(5), 459-469.
79. Liang, Z., Yoon, Y., Votaw, J., Goodman, M. M., Williams, L., & Shim, H. (2005). Silencing of CXCR4 blocks breast cancer metastasis. Cancer Research, 65(3), 967-971.
80. Kang, Y. B., Siegel, P. M., Shu, W. P., Drobnjak, M., Kakonen, S. M., Cordon-Cardo, C., et al. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 3(6), 537-549.
81. Ueda, Y., Neel, N. F., Schutyser, E., Raman, D., & Richmond, A. (2006). Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells. Cancer Research, 66(11), 5665-5675.
82. Cabioglu, N., Summy, J., Miller, C., Parikh, N. U., Sahin, A. A., Tuzlali, S., et al. (2005). CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Research, 65(15), 6493-6497.
83. Salvucci, O., Bouchard, A., Baccarelli, A., Deschenes, J., Sauter, G., Simon, R., et al. (2006). The role of CXCR4 receptor expression in breast cancer: A large tissue microarray study. Breast Cancer Research and Treatment, 97(3), 275-283.
84. Kato, M., Kitayama, J., Kazama, S., & Nagawa, H. (2003). Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Research, 5(5), R144-R150.
85. Burger, M., Glodek, A., Hartmann, T., Schmitt-Graff, A., Silberstein, L. E., Fujii, N., et al. (2003). Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene, 22(50), 8093-8101.
86. Hartmann, T. N., Burger, J. A., Glodek, A., Fujii, N., & Burger, M. (2005). CXCR4 chemokine receptor and integrin signaling cooperate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene, 24(27), 4462-4471.
87. Su, L. P., Zhang, J. P., Xu, H. B., Chen, J., Wang, Y., & Xiong, S. D. (2005). The role of CXCR4 in lung cancer metastasis and its possible mechanism. Zhonghua Yixue Zazhi, 85(17), 1190-1194.
88. Kijima, T., Maulik, G., Ma, P. C., Tibaldi, E. V., Turner, R. E., Rollins, B., et al. (2002). Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Research, 62(21), 6304-6311.
89. Phillips, R. J., Mestas, J., Gharee-Kermani, M., Burdick, M. D., Sica, A., Belperio, J. A., et al. (2005). Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1 alpha. Journal of Biological Chemistry, 280(23), 22473-22481.
90. Jankowski, K., Kucia, M., Wysoczynski, M., Reca, R., Zhao, D., Trzyna, E., et al. (2003). Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Cancer Research, 63(22), 7926-7935.
91. Geminder, H., Sagi-Assif, O., Goldberg, L., Meshel, T., Rechavi, G., Witz, I. P., et al. (2001). A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. Journal of Immunology, 167(8), 4747-4757.
92. Scala, S., Ottaiano, A., Ascierto, P. A., Cavalli, M., Simeone, E., Giuliano, P., et al. (2005). Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clinical Cancer Research, 11(5), 1835-1841.
93. Matsunaga, T., Takemoto, N., Sato, T., Takimoto, R., Tanaka, I., Fujimi, A., et al. (2003). Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nature Medicine, 9(9), 1158-1165.
94. Sanz-Rodriguez, F., Hidalgo, A., & Teixido, J. (2001). Chemokine stromal cell-derived factor-1 alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. Blood, 97(2), 346-351.
95. Scotton, C. J., Wilson, J. L., Scott, K., Stamp, G., Wilbanks, G. D., Fricker, S., et al. (2002). Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Research, 62(20), 5930-5938.
96. Paget, S. (1889). The distribution of secondary growths in cancer of the breast. Lancet, 1, 571-573.
97. Li, L., & Neaves, W. B. (2006). Normal stem cells and cancer stem cells: The niche matters. Cancer Research, 66(9), 4553-4557.
98. Yilmaz, O. H., Valdez, R., Theisen, B. K., Guo, W., Ferguson, D. O., Wu, H., et al. (2006). Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature, 441, 475-482.
99. Rak, J. (2006). Is cancer stem cell a cell, or a multicellular unit capable of inducing angiogenesis? Medical Hypotheses, 66(3), 601-604.
100. Polyak, K., & Hahn, W. C. (2006). Roots and stems: Stem cells in cancer. Nature Medicine, 12(3), 296-300.
101. Clarke, M. F., & Fuller, M. (2006). Stem cells and cancer: Two faces of eve. Cell, 124(6), 1111-1115.
102. Begley, L., Monteleon, C., Shah, R. B., Macdonald, J. W., & Macoska, J. A. (2005). CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro. Aging Cell, 4(6):291-298.
103. Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438(7069), 820-827.
104. Bradstock, K. F., Makrynikola, V., Bianchi, A., Shen, W., Hewson, J., & Gottlieb, D. J. (2000). Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers. Leukemia, 14(5), 882-888.
105. Loetscher, P., Gong, J. H., Dewald, B., Baggiolini, M., & Clark-Lewis, I. (1998). N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. Journal of Biological Chemistry, 273(35), 22279-22283.
106. Obrien, W. A., SumnerSmith, M., Mao, S. H., Sadeghi, S., Zhao, J. Q., & Chen, I. Y. (1996). Anti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactions. Journal of Virology, 70(5), 2825-2831.
107. Tamamura, H., Sugioka, M., Odagaki, Y., Omagari, A., Kan, Y., Oishi, S., et al. (2001). Conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity. Bioorganic & Medicinal Chemistry Letters, 11(3), 359-362.
108. Liang, Z. X., Wu, T., Lou, H., Yu, X. W., Taichman, R. S., Lau, S. K., et al. (2004). Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Research, 64(12), 4302-4308.
109. Jordan, N. J., Kolios, G., Abbot, S. E., Sinai, M. A., Thompson, D. A., Petraki, K., et al. (1999). Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. Journal of Clinical Investigation, 104(8), 1061-1069.
110. Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A., Sun, Y. P., Schmidt, K., et al. (2003). A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13513-13518.
111. Taichman, R. S., Cooper, C., Keller, E. T., Pienta, K. J., Taichman, N., & McCauley, L. K. (2002). Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Research, 62, 1832-1837.
112. Cooper, C. R., Sikes, R. A., Nicholson, B. E., Sun, Y. X., Pienta, K. J., & Taichman, R. S. (2004). Cancer cells homing to bone: the significance of chemotaxis and cell adhesion. Cancer Treatment and Research, 118, 291-309.
113. Tashiro, K., Tada, H., Heilker, R., Shirozu, M., Nakano, T., & Honjo, T. (1993). Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science, 261, 600-603.
114. McGrath, K. E., Koniski, A. D., Maltby, K. M., McGann, J. K., & Palis, J. (1999). Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Developments in Biologicals, 213(2), 442-456.
115. Mohle, R., Moore, M. A., Nachman, R. L., & Rafii, S. (1997). Transendothelial migration of CD34+ and mature hematopoietic cells: An in vitro study using a human bone marrow endothelial cell line. Blood, 89(1), 72-80.
116. Robledo, M. M., Bartolome, R. A., Longo, N., Rodriguez-Frade, J. M., Mellado, M., Longo, I., et al. (2001). Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. Journal of Biological Chemistry, 276(48), 45098-45105.
117. Gerritsen, M. E., Peale, F. V. Jr., & Wu, T. (2002). Gene expression profiling in silico: Relative expression of candidate angiogenesis associated genes in renal cell carcinomas. Experimental Nephrology, 10(2), 114-119.
118. Koshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., et al. (2000). Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: A possible role for tumor progression. Clinical Cancer Research, 6(9), 3530-3535.
119. Eitner, F., Cui, Y., Hudkins, K. L., & Alpers, C. E. (1998). Chemokine receptor (CXCR4) mRNA-expressing leukocytes are increased in human renal allograft rejection. Transplantation, 66(11), 1551-1557.